MTI's Solamichi system invests in AI medication firm Corte

MTI Ltd. [TSE:9438] announced today that its consolidated subsidiary, Solamichi System Inc., will invest in corte Inc., a company specializing in AI-powered medication history support services. The investment, through a third-party share allotment, will result in Solamichi System owning 20% of corte. This move aims to strengthen the existing business collaboration between the two companies, which have jointly developed the "corte" tool, an AI-driven solution integrated into Solamichi System's "CARADA Electronic Medication History Solamichi" service. The investment is intended to improve pharmacists' efficiency and enhance medication guidance quality. MTI anticipates a minimal impact on its consolidated earnings for the fiscal year ending September 2025. Corte, established in August 2023, provides AI-powered medication history support services and had a capital stock of 15 million yen as of December 31, 2024.